Trial Profile
Phase I trial of PDS0102A in patients in patients with ovarian cancer
Status:
Planning
Phase of Trial:
Phase I
Latest Information Update: 11 Feb 2016
Price :
$35
*
At a glance
- Drugs PDS 0102 (Primary)
- Indications Ovarian cancer
- Focus Adverse reactions
- Sponsors PDS Biotechnology Corporation
- 11 Feb 2016 New trial record